Form 4: Xometry CEO Randolph Altschuler Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Xometry CEO Randolph Altschuler sold 27,566 shares of Class A Common Stock on February 28, 2025, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- On February 28, 2025, Randolph Altschuler, the CEO of Xometry, Inc., sold 27,566 shares of Class A Common Stock.
- The sale was executed under a Rule 10b5-1 trading plan adopted at least 90 days prior to the transaction date.
- The shares were sold at a weighted average price of $26.5995, with individual transactions ranging from $26.21 to $27.11.
- A portion of the shares were sold to cover tax withholding obligations related to the vesting of restricted stock units granted in March 2024.
- Following the transaction, Altschuler directly owns 256,570 shares of Class A Common Stock and 1,475,311 shares of Class B Common Stock.
- Altschuler also has indirect ownership of Class A Common Stock through various trusts and his spouse, totaling 2,472,999 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the document simply reports an insider stock sale under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which is generally viewed as a transparent and orderly way for insiders to sell shares.
Industry Context
Insider sales are a common occurrence, and the use of a 10b5-1 plan suggests a planned and orderly approach to selling shares. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally less informative than discretionary trades.
Stakeholder Impact
- The stock sale could have a minor negative impact on shareholder sentiment, although the use of a 10b5-1 plan may mitigate concerns.
Key Dates
| Date | Description |
|---|---|
| March 2024 | Restricted stock units granted to Randolph Altschuler subject to performance-based vesting conditions pertaining to 2024 performance. |
| 02/28/2025 | Date of the stock sale transaction. |
| 03/04/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.